Dutch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

atrophy/obesitas

De link wordt op het klembord opgeslagen
Bladzijde 1 van 55 resultaten

Screening methods for compounds useful for the treatment of body weight disorders, including obesity

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
1. INTRODUCTION The present invention relates to the mammalian tubby (tub) genes, including the human tub gene, which are novel genes involved in the control of mammalian body weight, including recombinant DNA molecules, cloned genes or degenerate variants thereof. The present invention further

Compositions for the treatment and diagnosis of body weight disorders, including obesity

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
1. INTRODUCTION The present invention relates to the mammalian tubby (tub) genes, including the human tub gene, which are novel genes involved in the control of mammalian body weight, including recombinant DNA molecules, cloned genes or degenerate variants thereof. The present invention further

Administration of nicotinamide mononucleotide in the treatment of disease

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
INTRODUCTION Age-related obesity is a health-related problem for which new treatments and methods of ameliorating, mitigating, or reversing are needed. U.S. Pat. No. 8,268,575 to Imai, S., et al. asserts that "Chemical effectors for mammalian NAD biosynthesis can mediate a variety of anti-aging

Administration of nicotinamide mononucleotide in the treatment of disease

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
INTRODUCTION Age-related obesity is a health-related problem for which new treatments and methods of ameliorating, mitigating, or reversing are needed. U.S. Pat. No. 8,268,575 to Imai, S., et al. asserts that "Chemical effectors for mammalian NAD biosynthesis can mediate a variety of anti-aging

2-Aminoquinoline compounds

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION Obesity, defined as excess adiposity for a given body size, results from a chronic imbalance between energy intake and energy expenditure. Body mass index (BMI, kg/m.sup.2) is an accepted clinical estimate of being overweight (BMI 25 to 30) and of obesity (BMI>30). A

Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-.alpha. modulators

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION The present invention relates to certain novel compounds, methods for preparing compounds, compositions, intermediates and derivatives thereof and for treating conditions such as cancer, arthritis, inflammatory airway disease, and metabolic disorders. More particularly, the

Melanocortin receptor ligands

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION The present invention relates to new melanocortin receptor ligands. These ligands are cyclic peptide analogs that preferably exhibit selectivity for the MC-4 and/or the MC-3 receptors relative to the other melanocortin receptors (in particular the MC-1 receptor). BACKGROUND OF

Adamantanamines and neramexane salts of thiomolybdic and thiotungstic acids

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION The present invention concerns the preparation and uses of adamantanamines (e.g. memantine, amantadine and rimantadine) and neramexane(s) salts of thiomolybdic acids and thiotungstic acids. Their pharmaceutical compositions incorporate two complementary, bioavailable

Thiazole derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION The subject invention relates to thiazole derivatives, pharmaceutical compositions comprising such derivatives and methods of using such derivatives to treat abnormal cell growth and certain diseases and conditions of the central nervous system. The compounds of the present

Imidazole derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION The subject invention relates to imidazole derivatives, pharmaceutical compositions comprising such derivatives and methods of using such derivatives to treat abnormal cell growth and certain diseases and conditions of the central nervous system. The compounds of the present

Imidazole derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION The subject invention relates to imidazole derivatives, pharmaceutical compositions comprising such derivatives and methods of using such derivatives to treat abnormal cell growth and certain diseases and conditions of the central nervous system. The compounds of the present

Deuterium-enriched pyridinonecarboxamides and derivatives

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
SUMMARY OF THE INVENTION The present invention is concerned with deuterium-enriched pyridinonecarboxamides and derivatives thereof of formula 1, ##STR00002## Wherein, R.sub.1 and R.sub.2 are independently, H, D (deuterium with enrichment of 1%-100%), F, Cl, CD.sub.3 (methyl-d.sub.3),

Anti-ACTH antibodies and use thereof

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
SEQUENCE DISCLOSURE The instant application contains a Sequence Listing, which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy, created on May 23, 2017, is named "43257o5404.txt" and is 541,238 bytes in size. FIELD This invention

Anti-ACTH antibodies and use thereof

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
SEQUENCE DISCLOSURE The instant application contains a Sequence Listing, which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy, created on Feb. 20, 2015, is named "43257o5402. txt" and is 541,162 bytes in size. FIELD This

Humanized anti-ACTH antibodies and use thereof

Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
SEQUENCE DISCLOSURE The instant application contains a Sequence Listing, which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. The ASCII copy, created on Dec. 18, 2014, is named "43257o5600.txt" and is 681,004 bytes in size. FIELD This
Word lid van onze
facebookpagina

De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap

  • Werkt in 55 talen
  • Kruidengeneesmiddelen gesteund door de wetenschap
  • Kruidenherkenning door beeld
  • Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
  • Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
  • Zoek medicinale kruiden op hun effecten
  • Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten

Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek

Google Play badgeApp Store badge